Safety and effectiveness of the TactiFlex duo system: 6-month results of the FOCALFLEX study
Europace · 06.05.2026 · 28 (5)
DOI: 10.1093/europace/euag108 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Europace, online erschienen am 07.05.2026. Verfasst von Martin Manninger und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, Graz A-8036, Austria. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Abbott, National Health, Medical Research Council of Australia.
Abstract (Originalsprache)
Aims
A dual-energy ablation system was developed to optimize targeted energy delivery via a flexible-tip, contact-force sensing catheter with electroanatomic mapping integration. This is the first report of long-term safety and effectiveness results of this system for ablation of paroxysmal atrial fibrillation (PAF). Methods and results The FOCALFLEX study is a prospective, multicentre study. Patients with PAF were enrolled between August 2024 and January 2025, with 144 patients (62.0 ± 10.0 years, 62.6% male) undergoing ablation with the TactiFlex PFA System at 21 sites worldwide. Primary safety and effectiveness endpoints were the rate of pre-defined serious adverse events within 7 days and the 6-month freedom from documented AF/AFL/AT episodes >30 s after a 90-day blanking period. Pulmonary vein isolation (PVI) was performed in each case with pulsed field required for posterior left atrium (LA) ablation and radiofrequency (RF) for cavotricuspid isthmus or near coronary arteries. Non-PV targets and modality were at physician’s discretion. Acute effectiveness was confirmed via entrance block and post-ablation LA voltage map after a 20-min waiting period and was achieved in 99.6% (566/568) of treated PVs with 95.5 ± 37.1 pulsed field ablation (PFA) applications/patients. Procedure, fluoroscopy, LA dwell, and PV ablation times were 112.2 ± 29.5, 7.6 ± 5.7, 81.1 ± 19.7, and 47.4 ± 16.4 min, respectively. There were two (1.4%) primary safety events. At 6 months, 81.0% of subjects were free from documented arrhythmia recurrence and the protocol-defined primary effectiveness rate was 79.6%. There was one repeat ablation (0.7%) after the blanking period through 6 months.
Conclusion
The FOCALFLEX study results demonstrate safety and effectiveness of a novel dual-mode RF/PFA system through 6 months of follow-up to treat symptomatic, recurrent PAF. Clinical trial registration ClinicalTrials.gov Identifier: NCT06271967
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Division of Cardiology, Medical University of Graz, Auenbruggerplatz 15, Graz A-8036, Austria.
- Ceske Budejovice Hospital and Faculty of Health and Social Sciences, University of South Bohemia, Ceske Budějovice, Czechia.
- Melbourne Heart Center, The Royal Melbourne Hospital, Parkville, Melbourne, VIC 3050, Australia.
- University of Melbourne, Parkville, Melbourne, VIC 3050, Australia.
- Centre for Heart Rhythm Disorders, Adelaide University and the Royal Adelaide Hospital, Adelaide, SA, Australia.
- Cardiac Arrhythmology and Electrophysiology Unit, Ospedale San Raffaele, Milan, Italy.
ORCID-Profile: Martin Manninger, Daniel Scherr, Alan Bulava, Jonathan Kalman, Prashanthan Sanders, Paolo Della Bella, Martin Reinhold Martinek, Isabel Deisenhofer, Adrianus P Wijnmaalen, Joaquin Osca, Ignacio García Bolao, Javier Moreno, Pierre Jaïs, Mads Brix Kronborg, Estelle Gandjbakhch, Helmut Pürerfellner, Sara Muldoon, Nick Dirckx, Virginia Woods, John Silberbauer
Förderung
- Abbott
- National Health
- Medical Research Council of Australia
Zitieren
APA
Manninger, M., Scherr, D., Bulava, A., Kalman, J., Sanders, P., Della Bella, P., Martinek, M. R., Deisenhofer, I., Wijnmaalen, A. P., Osca, J., Bolao, I. G., Moreno, J., Jaïs, P., Kronborg, M. B., Gandjbakhch, E., Pürerfellner, H., Muldoon, S., Dirckx, N., Woods, V., & Silberbauer, J. (2026). Safety and effectiveness of the TactiFlex duo system: 6-month results of the FOCALFLEX study. Europace, 28(5). https://doi.org/10.1093/europace/euag108
Vancouver
Manninger M, Scherr D, Bulava A, Kalman J, Sanders P, Della Bella P, et al. Safety and effectiveness of the TactiFlex duo system: 6-month results of the FOCALFLEX study. Europace. 2026;28(5). doi:10.1093/europace/euag108
BibTeX
@article{Manninger2026,
author = {Manninger, Martin and Scherr, Daniel and Bulava, Alan and Kalman, Jonathan and Sanders, Prashanthan and Della Bella, Paolo and Martinek, Martin Reinhold and Deisenhofer, Isabel and Wijnmaalen, Adrianus P and Osca, Joaquin and Bolao, Ignacio García and Moreno, Javier and Jaïs, Pierre and Kronborg, Mads Brix and Gandjbakhch, Estelle and Pürerfellner, Helmut and Muldoon, Sara and Dirckx, Nick and Woods, Virginia and Silberbauer, John},
title = {Safety and effectiveness of the TactiFlex duo system: 6-month results of the FOCALFLEX study},
journal = {Europace},
year = {2026},
volume = {28},
number = {5},
doi = {10.1093/europace/euag108}
}
EUVIMED